Clinical Trial Update: Allergy Immunotherapy for the Reduction of Asthma [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 trial assessing allergy immunotherapy aimed at reducing asthma symptoms has completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Allergy immunotherapy

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Wheezing, Asthma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-28